Frederick Financial Consultants’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$247K Buy
213
+18
+9% +$21.2K 0.1% 105
2026
Q2
$234K Buy
+195
New +$199K 0.1% 108
2026
Q1
– Sell
-214
Closed -$230K – 113
2025
Q4
$230K Buy
+214
New +$205K 0.13% 97

Other funds holding LLY

Frederick Financial Consultants's LLY Position: Q3 2026 in Review

Frederick Financial Consultants increased its Eli Lilly (LLY) stake by 9.2% in Q3 2026, buying an estimated $21.2K and bringing the position to 213 shares worth $247K. The position accounts for 0.1% of the portfolio, ranked #105.

Frederick Financial Consultants first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Frederick Financial Consultants held 213 shares of Eli Lilly worth $247K as of Q3 2026.
  • Frederick Financial Consultants bought 18 Eli Lilly shares in Q3 2026, an estimated $21.2K.
  • Eli Lilly made up 0.1% of Frederick Financial Consultants's portfolio in Q3 2026, its #105 holding.
  • Frederick Financial Consultants first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Frederick Financial Consultants's 13F filing for Q3 2026, filed 29 Oct 2026.